Repository logo
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Српски
  • Yкраї́нська
  • Log In
    New user? Click here to register. Have you forgotten your password?
Repository logo
  • Communities & Collections
  • All of DSpace
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Српски
  • Yкраї́нська
  • Log In
    New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Akar, M. Nejat"

Now showing 1 - 3 of 3
Results Per Page
Sort Options
  • No Thumbnail Available
    Item
    Çocukluk çağı tromboz olgularında faktör V 1691 G-A değişiminin tromboz oluşumuna yaş değişiminin etkisinin araştırılması
    (Biyoteknoloji Enstitüsü, 2009) Güngör, Esin; Akar, M. Nejat; Biyoteknoloji
    Human coagulation factor V (FV) is an essential coagulation protein with functions in both the pro - and anticoagulant pathways. Failure to express and control FV functions can either lead to bleeding, or to thromboembolic disease. The most common inherited risk factor for thrombosis is a single point mutation in the blood coagulation factor V gene (G1691A), which results in phenotype called APC Resistance. The mutation, which occurs at one of the APC cleavage sites factor V, is located at nucleotide position 1691 and substitutes a G for an A, correspending to the replacement of arginine with glutamine at codon 506. The mutant factor V is known as ?Factor V R506Q? or ?Factor V Leiden (FVL)? and FVL has full procoagulant capacity.In this study, we studied correlation between FVL 1691 G > A mutation and age alterations in pediatric thrombosis. We found the risky age groups for thrombosis in pediatric thrombosis. Two groups of children were selected, i.e with thrombus attack (n=372) and age matched non-thrombotic group (n=336).We used the Kaplan ? Meier statistical method for statistical analysis. We compare two groups for Factor V Leiden mutation. We found that, 1691 G > A mutation in factor V gene is effective on thrombosis.
  • No Thumbnail Available
    Item
    Complete remission of nephrotic syndrome in secondary amyloidosis of familial Mediterranean fever following colchicine treatment
    (2005) Düzgün, Nurşen; Şahinalp, Mehmet Sait; Akar, M. Nejat; Kuzu, Işınsu; Ensari, Arzu; Tulunay, Özden
  • No Thumbnail Available
    Item
    Mycobacterium tuberculosis suşlarının polimeraz zincir reaksiyonu (PZR) yöntemi ile genotiplendirilmesi
    (2007) Karahan, Zeynep Ceren; Tekeli Atalay, Alper; Akar, M. Nejat

DSpace software copyright © 2002-2025 LYRASIS

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback